1-15 of 715
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
NeuroFrontiersRethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Project Oncology®Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiersBridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiersAdvancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiersUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
- advertisement
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiersHarnessing AI to Predict and Prevent Schizophrenia Relapse
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiersEngaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiersApplying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Aducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
NeuroFrontiersAducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
Project Oncology®Evaluating Digital CBT for Sickle Cell Disease: Insights From the CaRISMA Trial
- advertisement
Understanding and Treating Trauma in Pediatric Patients: Key Management Strategies
Clinician's RoundtableUnderstanding and Treating Trauma in Pediatric Patients: Key Management Strategies
Sustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
Psychiatry and Mental HealthSustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
Seltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
Psychiatry and Mental HealthSeltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
